IGF2BP1 stabilizes Akt2 mRNA to promote glucose metabolism and maintain spermatogonial proliferation

Reproduction (Cambridge, England)
|February 4, 2025
PubMed

Insights

Insulin-like growth factor-2 mRNA-binding protein 1 (IGF2BP1) stabilizes Akt2 mRNA, promoting spermatogonial proliferation and glucose metabolism. Downregulation of IGF2BP1 and Akt2 is linked to male infertility in cryptorchid patients.

Area of Science:

  • Reproductive Biology
  • Molecular Endocrinology
  • Epigenetics

Background:

  • Spermatogonial proliferation dysregulation is a key factor in male infertility.
  • The role of N6-methyladenosine (m6A) methylation reader insulin-like growth factor-2 mRNA-binding protein 1 (IGF2BP1) in male germ cell development is not well understood.
  • IGF2BP1 is known to influence mRNA stability, splicing, and translation.

Purpose of the Study:

  • To elucidate the function and mechanism of IGF2BP1 and its target Akt2 in mouse spermatogonia.
  • To investigate the role of IGF2BP1 in maintaining spermatogonial proliferation and glucose metabolism.
  • To explore the potential of IGF2BP1 as a therapeutic target for male infertility.

Main Methods:

  • Western blotting and immunofluorescence to confirm IGF2BP1 expression.
  • RNA sequencing, dual luciferase reporter assays, RIP-qPCR, and mRNA stability experiments to identify and validate Akt2 as an IGF2BP1 target.
  • Co-immunoprecipitation and mass spectrometry to identify interacting proteins; knockdown experiments to assess functional impacts on proliferation and metabolism.

Main Results:

  • IGF2BP1 is highly expressed in mouse spermatogonia and its downregulation inhibits proliferation.
  • IGF2BP1 stabilizes Akt2 mRNA in an m6A-dependent manner, promoting spermatogonial proliferation.
  • IGF2BP1 knockdown, along with Akt2, reduces glucose and ATP levels, indicating a role in glucose metabolism homeostasis. IGF2BP1 and AKT2 are downregulated in human cryptorchidism patients with infertility.

Conclusions:

  • IGF2BP1 plays a crucial role in maintaining spermatogonial proliferation and glucose metabolism by stabilizing Akt2 mRNA.
  • The IGF2BP1-Akt2 pathway is essential for normal spermatogenesis.
  • Downregulation of IGF2BP1 and Akt2 expression in cryptorchidism suggests their involvement in male infertility, highlighting them as potential therapeutic targets.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K